中文 | English
Return
Total: 2581 , 1/259
Show Home Prev Next End page: GO
Author:(Wei SU)

1.Analysis and Accounting on Applying Software in the Management of Hospital Intangible Assets

Wei SU

Chinese Health Economics 2013;(11):90-92

2.Should recanalization devices only be restricted to clinical trials?

Kejiang SU ; Wei ZHANG

International Journal of Cerebrovascular Diseases 2010;18(2):157-160

3.Effect of fondaparinux sodium in the prevention of deep vein thromboembolism after surgery on lower limbs

Wei SU ; Lili ZHANG

Chinese Journal of Biochemical Pharmaceutics 2016;36(8):68-70

4.Analysis of abnormal Hepatitis B virus serological markers in neonatals

Wei SU ; Huiqing FENG

Journal of Clinical Pediatrics 2014;(6):544-546

5.Progress in correlation of long non-coding RNA with breast cancer invasion and metastasis

Wei SU ; Jin ZHANG

Tianjin Medical Journal 2015;43(5):566-569

6.Orexin A and cerebrovascular diseases

Wei HE ; Zhiqiang SU

International Journal of Cerebrovascular Diseases 2015;(5):374-377

7.Clinical observation of cervical intra-epithelial neoplasia with high risk HPV infection after LEEP treatment

Xuan SU ; Wei WU

Chinese Journal of Primary Medicine and Pharmacy 2013;20(16):2462-2464

8.Relationship between glycosylated hemoglobin and carotid artery atherosclerosis in aged patients with normal glucose tolerance

Su DAN ; Wei XUAN

Chinese Journal of cardiovascular Rehabilitation Medicine 2014;23(4):404-407

9.Evaluation of Rabbit Skin Irritation and in vitro Transdermal Absorption of Diclofenac Sodium Microemul-sion

Yu WEI ; Chengfu SU

China Pharmacy 2017;28(4):490-492,493

10.Therapeutic effect of rehmannia polysaccharide on diabetic nephropathy rat model and its effects on PPARγsignal pathway

Wei KANG ; Su WANG

Chinese Journal of Biochemical Pharmaceutics 2015;(9):30-33,37

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2581 , 1/259 Show Home Prev Next End page: GO